Next weeks shut down

Discussion in 'Amarin' started by anonymous, Sep 7, 2019 at 7:01 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Because os an unexpected FDA decision of an advisory committee meeting implies a delayed commercial launch of Vascepa in an expanded indication. This, in turn, will result in lower-than-expected uptake of the drug in 2019-22, so long suckers.